>
Fa   |   Ar   |   En
   SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection  
   
نویسنده berger a. ,sommer a.f.r. ,zwarg j. ,hamdorf m. ,welzel k. ,esly n. ,panitz s. ,reuter a. ,ramos i. ,jatiani a. ,mulder l.c.f. ,fernandez-sesma a. ,rutsch f. ,simon v. ,könig r. ,flory e.
منبع plos pathogens - 2011 - دوره : 7 - شماره : 12
چکیده    Myeloid blood cells are largely resistant to infection with human immunodeficiency virus type 1 (hiv-1). recently,it was reported that vpx from hiv-2/sivsm facilitates infection of these cells by counteracting the host restriction factor samhd1. here,we independently confirmed that vpx interacts with samhd1 and targets it for ubiquitin-mediated degradation. we found that vpx-mediated samhd1 degradation rendered primary monocytes highly susceptible to hiv-1 infection; vpx with a t17a mutation,defective for samhd1 binding and degradation,did not show this activity. several single nucleotide polymorphisms in the samhd1 gene have been associated with aicardi-goutières syndrome (ags),a very rare and severe autoimmune disease. primary peripheral blood mononuclear cells (pbmc) from ags patients homozygous for a nonsense mutation in samhd1 (r164x) lacked endogenous samhd1 expression and support hiv-1 replication in the absence of exogenous activation. our results indicate that within pbmc from ags patients,cd14+ cells were the subpopulation susceptible to hiv-1 infection,whereas cells from healthy donors did not support infection. the monocytic lineage of the infected samhd1 -/- cells,in conjunction with mostly undetectable levels of cytokines,chemokines and type i interferon measured prior to infection,indicate that aberrant cellular activation is not the cause for the observed phenotype. taken together,we propose that samhd1 protects primary cd14+ monocytes from hiv-1 infection confirming samhd1 as a potent lentiviral restriction factor. © 2011 berger et al.
آدرس division of medical biotechnology,paul-ehrlich-institute,langen, Germany, research group host-pathogen interactions,paul-ehrlich-institute,langen, Germany, division of medical biotechnology,paul-ehrlich-institute,langen, Germany, research group host-pathogen interactions,paul-ehrlich-institute,langen, Germany, division of medical biotechnology,paul-ehrlich-institute,langen, Germany, research group host-pathogen interactions,paul-ehrlich-institute,langen, Germany, division of medical biotechnology,paul-ehrlich-institute,langen, Germany, division of allergology,paul-ehrlich-institute,langen, Germany, department of microbiology,mount sinai school of medicine,new york,ny, United States, department of microbiology,mount sinai school of medicine,new york,ny, United States, department of microbiology,mount sinai school of medicine,new york,ny, United States, department of microbiology,mount sinai school of medicine,new york,ny,united states,the global health and emerging pathogens institute,mount sinai school of medicine,new york,ny,united states,division of infectious diseases,department of medicine,mount sinai school of medicine,new york,ny, United States, department of general pediatrics,münster university children's hospital,münster, Germany, department of microbiology,mount sinai school of medicine,new york,ny,united states,the global health and emerging pathogens institute,mount sinai school of medicine,new york,ny,united states,division of infectious diseases,department of medicine,mount sinai school of medicine,new york,ny, United States, research group host-pathogen interactions,paul-ehrlich-institute,langen,germany,infectious and inflammatory disease center,sanford-burnham medical research institute,la jolla,ca, United States, division of medical biotechnology,paul-ehrlich-institute,langen, Germany
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved